Structures by: Goodman J. M.
Total: 30
C24H26N2O6S
C24H26N2O6S
Organic letters (2013) 15, 6 1386-1389
a=7.52030(10)Å b=11.50070(10)Å c=13.57270(10)Å
α=90.00° β=100.4960(10)° γ=90.00°
C27H26N2O6S
C27H26N2O6S
Organic letters (2013) 15, 6 1386-1389
a=6.945(3)Å b=17.2536(5)Å c=20.6291(10)Å
α=90.00° β=90.00° γ=90.00°
C14H20O4S2
C14H20O4S2
Organic letters (2009) 11, 6 1373-1376
a=8.6297(5)Å b=10.2315(4)Å c=16.3301(9)Å
α=90.00° β=90.00° γ=90.00°
(1R,3R,5R,7R,8S,9S,10R)-rel-3,5-Diethyl-8,9,10- trimethyl-2,4,6-trioxatricyclo[3.3.1.13,7]decan-1-ol
C14H24O4
Organic letters (2009) 11, 6 1373-1376
a=11.3198(4)Å b=12.4182(7)Å c=10.0138(5)Å
α=90.00° β=103.718(3)° γ=90.00°
C18H32NO4,Br
C18H32NO4,Br
Organic letters (2008) 10, 20 4537-4540
a=7.9067(2)Å b=12.6246(3)Å c=10.7306(3)Å
α=90.00° β=110.1510(10)° γ=90.00°
C13H22O7
C13H22O7
Organic letters (2008) 10, 20 4537-4540
a=9.3234(2)Å b=9.6424(2)Å c=16.4602(4)Å
α=90.00° β=90.00° γ=90.00°
C16H22O5
C16H22O5
Organic letters (2008) 10, 20 4537-4540
a=6.1878(2)Å b=10.3959(3)Å c=24.2681(7)Å
α=90.00° β=90.00° γ=90.00°
C11H17NO5
C11H17NO5
Organic letters (2008) 10, 20 4537-4540
a=6.9222(3)Å b=8.7421(4)Å c=10.5953(5)Å
α=90.00° β=103.477(2)° γ=90.00°
C18H24N4O8
C18H24N4O8
Organic letters (2008) 10, 20 4537-4540
a=7.2898(2)Å b=9.3886(2)Å c=15.9051(6)Å
α=91.007(1)° β=97.177(1)° γ=111.934(1)°
4(C14H10Cl2NO21),4(Na1),19(H2O)
4(C14H10Cl2NO21),4(Na1),19(H2O)
Journal of medicinal chemistry (2007) 50, 5 979-983
a=9.55400(10)Å b=39.4910(4)Å c=9.84120(10)Å
α=90.00° β=90.7290(10)° γ=90.00°
C13H17N3O
C13H17N3O
Organic & biomolecular chemistry (2004) 2, 8 1258-1265
a=15.5820(9)Å b=9.9509(6)Å c=7.9189(5)Å
α=90.00° β=97.128(3)° γ=90.00°
C13H17N3O
C13H17N3O
Organic & biomolecular chemistry (2004) 2, 8 1258-1265
a=5.84160(10)Å b=6.9482(2)Å c=31.7123(12)Å
α=86.9810(10)° β=89.7330(10)° γ=68.6350(10)°
C13H17N3O1
C13H17N3O1
Organic & biomolecular chemistry (2004) 2, 8 1258-1265
a=12.610(3)Å b=12.464(3)Å c=16.763(3)Å
α=90° β=107.01(3)° γ=90°
C18H21NO4
C18H21NO4
Organic & Biomolecular Chemistry (2003) 1, 20 3570
a=7.0666(4)Å b=7.0975(4)Å c=18.3293(13)Å
α=88.437(3)° β=86.586(3)° γ=62.907(3)°
C8H22ClCuN4P2Se2,3(C4H8O)
C8H22ClCuN4P2Se2,3(C4H8O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 11 3403-3407
a=10.2274(3)Å b=9.4057(3)Å c=16.1265(5)Å
α=90° β=96.507(2)° γ=90°
C34H53CuN4P3Se2,BF4
C34H53CuN4P3Se2,BF4
Dalton transactions (Cambridge, England : 2003) (2020) 49, 11 3403-3407
a=11.3820(3)Å b=13.3316(3)Å c=28.1088(7)Å
α=90° β=98.8212(14)° γ=90°
C52H68N4P4PdSe22,2(BF4),CH2Cl2
C52H68N4P4PdSe22,2(BF4),CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 11 3403-3407
a=10.8880(4)Å b=19.8347(7)Å c=28.1508(9)Å
α=90° β=90.458(2)° γ=90°
C32H72N8O4P8
C32H72N8O4P8
Dalton Transactions (2009) 8 1293
a=13.3176(1)Å b=17.0622(2)Å c=21.4828(3)Å
α=90.00° β=90.00° γ=90.00°
C28H46N6P4S2
C28H46N6P4S2
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=9.0091(18)Å b=9.3028(19)Å c=20.968(4)Å
α=87.66(3)° β=89.25(3)° γ=79.64(3)°
C20H30N4P2S2
C20H30N4P2S2
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=14.756(3)Å b=9.0309(18)Å c=17.947(4)Å
α=90.00° β=97.74(3)° γ=90.00°
C28H46N6O2P4
C28H46N6O2P4
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=8.8275(18)Å b=10.307(2)Å c=10.362(2)Å
α=68.10(3)° β=73.40(3)° γ=75.00(3)°
C20H30N4O2P2
C20H30N4O2P2
Dalton transactions (Cambridge, England : 2003) (2005) 10 1764-1773
a=11.308(2)Å b=13.578(3)Å c=15.342(3)Å
α=103.49(3)° β=96.66(3)° γ=91.07(3)°
C16H36N4P4
C16H36N4P4
Chemical communications (Cambridge, England) (2009) 43 6637-6639
a=15.8849(2)Å b=69.0550(10)Å c=15.7466(3)Å
α=90.00° β=106.4990(10)° γ=90.00°
C16H22O5
C16H22O5
Organic letters (2008) 10, 20 4537-4540
a=22.3552(4)Å b=6.7979(2)Å c=11.9364(3)Å
α=90.00° β=117.424(2)° γ=90.00°
Sulindac
C20H17F1O3S1
Journal of Applied Crystallography (2007) 40, 2 379-381
a=12.68581(34)Å b=8.18939(20)Å c=17.7934(5)Å
α=90.0° β=106.0111(29)° γ=90.0°
Amodiaquinium dihydrochloride dihydrate
C20H24Cl1N3O2,2Cl,2H2O
Acta Crystallographica Section E (2006) 62, 9 o4196-o4199
a=7.83868(10)Å b=26.9917(5)Å c=10.80804(18)Å
α=90° β=92.9632(13)° γ=90°
C10H15NO
C10H15NO
Journal of the American Chemical Society (2015) 137, 2 926-930
a=12.744(2)Å b=6.6351(9)Å c=10.4218(9)Å
α=90.00° β=90.00° γ=90.00°
C9H14NO1,BF41
C9H14NO1,BF41
Journal of the American Chemical Society (2015) 137, 2 926-930
a=7.5632(4)Å b=6.7319(3)Å c=20.566(2)Å
α=90.00° β=96.578(3)° γ=90.00°
Sparfloxamine trihydrate
C19H22F2N4O3,3(H2O)
Crystal Growth & Design (2008) 8, 1 114
a=9.1250(13)Å b=10.3010(15)Å c=11.8890(17)Å
α=90.00° β=109.207(2)° γ=90.00°
C19H22F2N4O3,3(H2O)
C19H22F2N4O3,3(H2O)
Crystal Growth & Design (2008) 8, 1 114
a=9.1533(3)Å b=10.3248(4)Å c=11.9341(4)Å
α=90.00° β=109.221(2)° γ=90.00°